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Abstract
Background: Successful reprogramming of a somatic genome to produce a healthy clone by
somatic cells nuclear transfer (SCNT) is a rare event and the mechanisms involved in this process
are poorly defined. When serial or successive rounds of cloning are performed, blastocyst and full
term development rates decline even further with the increasing rounds of cloning. Identifying the
"cumulative errors" could reveal the epigenetic reprogramming blocks in animal cloning.
Results: Bovine clones from up to four generations of successive cloning were produced by
chromatin transfer (CT). Using Affymetrix bovine microarrays we determined that the
transcriptomes of blastocysts derived from the first and the fourth rounds of cloning (CT1 and CT4
respectively) have undergone an extensive reprogramming and were more similar to blastocysts
derived from in vitro fertilization (IVF) than to the donor cells used for the first and the fourth
rounds of chromatin transfer (DC1 and DC4 respectively). However a set of transcripts in the
cloned embryos showed a misregulated pattern when compared to IVF embryos. Among the genes
consistently upregulated in both CT groups compared to the IVF embryos were genes involved in
regulation of cytoskeleton and cell shape. Among the genes consistently upregulated in IVF
embryos compared to both CT groups were genes involved in chromatin remodelling and stress
coping.
Conclusion: The present study provides a data set that could contribute in our understanding of
epigenetic errors in somatic cell chromatin transfer. Identifying "cumulative errors" after serial
cloning could reveal some of the epigenetic reprogramming blocks shedding light on the
reprogramming process, important for both basic and applied research.
Background
The process of early embryonic development is deter-
mined by activation of the embryonic genome, which for
bovine embryos begins as a "minor genome activation" at
the 1-cell stage [1] ascending to a "major genome activa-
tion" during the 8-cell to 16-cell stage [2]. In the absence
of proper genome activation, the developing embryo will
die because it can no longer support its essential develop-
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by somatic cell nuclear transfer (SCNT) the somatic
nucleus has to be reprogrammed in order to restart and
continue the developmental process. It is believed that,
guided by the ooplasm, the somatic nucleus aborts its
own program of somatic gene expression and re-estab-
lishes a particular program of embryonic gene expression
necessary for normal embryo development [4].
Embryos produced by SCNT have lower developmental
rates than their in vitro and in vivo produced counterparts
[5]. Embryos produced by SCNT also have a greater inci-
dence of apoptosis and consequently a lower number of
cells [6]. Additionally, SCNT derived embryos have
greater rates of embryo and fetal mortality, stillbirths and
perinatal deaths, which bring down the overall efficiency
of cloning. These alterations may be caused, at least par-
tially, by incomplete epigenetic reprogramming of the
somatic nuclei [5,7]. Somatic cell chromatin transfer
(SCCT) attempts to facilitate the reprogramming process
by exposing the somatic cells, prior to the transfer, to a
mitotic cell extract, which is supposed to induce chromo-
some condensation and promote the removal and solubi-
lisation of nuclear factors, enhancing nuclear remodelling
[8]. Compared with nuclear transfer, SCCT shows greater
survival of cloned calves up to at least 1 month and could
be a useful tool in understanding the mechanisms of
reprogramming [8]. Remarkably, a recent study did not
detect any significant differences in the global gene
expression profiles of SCCT and SCNT embryos [9].
Embryos derived from nuclear transfer have an abnormal
pattern of DNA methylation, in some cases resembling
that of somatic cells [10-12]. This aberrant DNA methyla-
tion pattern has been inversely correlated with the devel-
opmental potential of the cloned embryos [13].
Treatment of donor cells with DNA demethylation agents,
prior the nuclear transfer, may remove epigenetic marks
improving the ability of the somatic cells to be fully repro-
grammed by the recipient karyoplast [14]. Global altera-
tion of gene expression has been another finding in
embryos produced by cloning. The abnormal expression
of genes playing important roles in early embryonic devel-
opment, implantation and fetal development is of partic-
ular interest. Conversely, other studies have reported a
significant reprogramming for SCNT embryos by the blas-
tocyst stage and similar transcriptome profiles to those of
embryos produced in vitro or in vivo, suggesting that
defects in gene expression for SCNT embryos may occur
later during redifferentiation and organogenesis [15,16].
Among the abnormally expressed genes reported in
bovine cloned embryos are IL6, FGF4, and FGFr2 [17];
FGF4, DNMT1, Mash2, HSP70, and interferon tau [18];
Acrogranin, Cdx2, and ERR2 [19]. Cytokeratin 19, Cytok-
eratin 8, Vimentin, Hsp27, Nidogen2 and MHC-I [20];
HDAC-1, 2, and 3, DNMT3A, and OCT4 [21]. Lower lev-
els of transcripts involved in the retinoic acid signalling
pathway (RARB, CRAB1, HLA-A, THBS2, and SERPINB5)
were reported for cloned bovine embryos [22]. There have
been conflicting results when it comes to the expression of
particular genes in SCNT and IVF embryos. Such is the
case of the developmentally important POU5F1 gene,
which has been reported as misregulated in cloned
embryos compared to IVF derived blastocysts in some
studies [21,23], while being detected at similar concentra-
tion in others [17,24].
SCNT is often used for the production of human proteins
in the milk of transgenic animals. For the achievement of
some specific transgenic phenotypes, multiple genetic
modifications need to be completed through sequential
modifications in primary cells prior to nuclear transfer
[25]. Since transfection and selection of transgenic cells
requires nearly the entire lifespan of a cell, only one
genetic modification can be completed in each cell
lifespan [26]. Therefore, consecutive rounds of cloning
(also referred to "repeated cloning", "serial cloning",
"recloning" or "nuclear recycling") are performed. It has
been proposed that consecutive rounds of cloning, allow
for rejuvenation and selection of transformed cultured
cells [27-30] and that it may improve the efficiency of
SCNT by increasing the reprogramming potential of the
somatic cells [31,32]. Conversely, other reports suggest
that epigenetic errors could accumulate in the embryos as
a result of serial cloning and prolonged in vitro culture
decreasing cloning efficiency. After serial cloning up to the
sixth generation was performed in mice, no signs of tel-
omere shortening or premature ageing were observed.
However, cloning efficiency significantly decreased with
increasing rounds of cloning [33]. A greatly reduced in
vitro and in vivo developmental capacity was reported for
bovine embryos derived after several rounds of serial clon-
ing [34,35]. It has been suggested that extended culture
associated with transfection and selection procedures may
induce changes of somatic cells, which decrease the effi-
ciency of nuclear transfer and that these changes cannot
be reversed by recloning [36].
The objective of the present study was to identify the
"cumulative errors" on global gene expression, caused by
serial rounds of chromatin transfer, by comparing the
transcriptome profile of IVF derived blastocysts to that of
SCCT derived blastocysts from the first and fourth rounds
of cloning (CT1 and CT4) using oligonucleotide microar-
ray analysis (Affymetrix Bovine GeneChips). Donor cells
used for first and fourth rounds of cloning (DC1 and
DC4) were also the target of the study as we compared the
global gene expression of the SCCT embryos with their
respective donor cells. Additionally, we analyzed thePage 2 of 23
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fibroblasts obtained from foetuses from zero to fifth
rounds of chromatin transfer. Our results show that a sub-
stantial reprogramming has taken place in the cloned
embryos from both generations of chromatin transfer.
However, there was a set of differential expressed genes in
both groups of cloned embryos compared to their IVF
counterparts. The number and functions of these genes
could suggest accumulative misregulations probably
caused by the successive rounds of cloning.
Results
Isolation of RNA
On average 12.2 ng of total RNA were isolated from pools
of 3 embryos (between 3.2 and 4.5 ng per blastocyst). The
RNA integrity ranged from 1.8 to 1.96, based on the ratio
between the 28S and 18S ribosomal RNA bands from the
Bioanalyzer gel-like image (Figure 1).
Transcriptome analyses
The Affymetrix GeneChip® Bovine Genome Array contains
24,129 probe sets representing over 23,998 bovine tran-
scripts, including assemblies from approximately 19,000
UniGene Clusters. In order to assess the influence of the
two cycles of linear amplification, on the representation
of original transcripts, we compared microarray experi-
ments from one-cycle and two-cycle amplifications using
total RNA from DC1. The results showed that amplifica-
tion of messages using 1 vs. 2 cycles were highly consistent
with a correlation coefficient of 0.93 (data not shown).
These data confirm the manufacturer's results using 1 and
2 cycles of linear amplification.
Microarray experiments were performed in three biologi-
cal replicates for all blastocysts (CT1, CT4 and IVF) and
donor cells (DC1 and DC4). Images were processed with
GCOS and data extracted using MAS 5.0. However, one of
the CT1 blastocyst chips did not pass the quality control
Agilent bioanalyzer gel-like image of total RNAFigure 1
Agilent bioanalyzer gel-like image of total RNA. The image shows a total RNA gel like-image produced by the Bioana-
lyzer. (Ten out of the 15 samples used in the microarray experiment are shown since no more than 11 samples can be run at 
one time). Lane L: Size markers. Lanes 1 and 2: total RNA from 106 donor cells used for the first round of embryonic cloning. 
Lanes 3 and 4: total RNA from 106 donor cell used for the fourth round of cloning. Lanes 5 and 6: total RNA from a pool of 3 
In Vitro Produced embryos. Lanes 7 and 8: total RNA from a pool of 3 embryos produced by the first round of chromatin 
transfer. Lanes 9 and 10: total RNA from a pool of 3 embryos produced by the fourth round of chromatin transfer. The 28S 
and 18s distinctive ribosomal RNA bands are observed for all samples.
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ses for CT1 are based on the remaining two chips in this
group, which showed an appropriate p-value distribution.
The GCOS software expression data report showed that
56% of the probe sets were called "Present" (P) for all
donor cell chips. This number was lower for all blastocyst
chips with 44%, 41%, and 47% for IVF, CT1, and CT4
respectively. Probe sets that were called "Absent" (A) in all
the samples were excluded from the analysis. Therefore
only 16,521 probe sets were included in the analysis.
Hierarchical clustering classified all donor cells chips in
one single group indicating small differences in their gene
expression profiles. All blastocysts were classified in 2 dis-
tinctive clusters with IVF blastocysts in one group and all
cloned blastocysts in other group (Figure 2).
In pairwise comparisons among transcripts with a p-value
< 0.01, a False Discovery Rate (FDR) of 20%, and a Fold
Change >2.0 were considered differentially expressed. The
numbers of differentially expressed transcripts in all pair-
wise comparisons are presented in Table 1. The number of
probe sets that were differentially expressed between all 3
groups of blastocysts was significantly lower compared to
the number of differentially expressed transcripts between
donor cells and embryos (P < 0.01). This numeric differ-
ence indicates that a substantial reprogramming has
occurred in cloned blastocysts from both first and fourth
rounds of cloning. However there were significantly less
differentially expressed transcripts between cloned
embryos and donor cells than between IVF blastocysts
and donor cells (P < 0.01). Out of 83 differentially
expressed transcripts between both cell lines, 79 corre-
sponded to absent or marginal signals, leaving only 4 dif-
ferentially expressed transcripts. Chemokine binding
protein 2 (CCBP2) and myocilin, trabecular meshwork
inducible glucocorticoid response (MYOC) were upregu-
lated in DC1 compared to DC4. Similar to hemicentin
(LOC528634) and similar to dolichyl pyrophosphate
phosphatase 1 (LOC504908) were the genes upregulated
in DC4 compared to DC1.
Because the bovine genome has not been fully annotated,
the annotation information available from NetAffx Anal-
ysis Center (Affymetrix) classifies probe sets as: 1) fully
annotated bovine genes; 2) transcripts similar to specific
genes, but not confirmed; 3) hypothetical proteins based
on sequence similarity; 4) cDNA clones; and 5) transcripts
with strong, moderate or weak similarity to genes from
other species. Table 2 presents a breakdown of the differ-
entially expressed transcripts according to these catego-
ries. Only transcripts corresponding to annotated bovine
genes were included in further analyses.
Multiple comparisons through one-way analysis of vari-
ance (ANOVA) using a Least Significant Differences (LSD)
test showed a set of 109 genes that were differentially
expressed in the cloned embryos and donor cells com-
pared to their IVF counterparts. Out of 109 genes, 67 were
upregulated in IVF embryos compared to CT embryos and
donor cells (top 30 in Table 3). Forty two genes were
upregulated in CT embryos (top 30 in Table 4).
Functional classification of genes
The Gene Ontology (GO) information for each probe set
recovered from NetAffx Analysis Center (Bovine Gene-
Chip November 2007 annotation) was still incomplete
for several probe sets, which lacked annotation for at least
one of the three ontologies Biological Process (BP),
Molecular Function (MF), and Cellular Component (CC).
The annotation was complemented with information
retrieved using the GOAnna tool part of the AgBase
resource at Mississippi State University. All the GO terms
associated to each gene were uploaded into the AgBase
tool GOSlimViewer in order to obtain a high level sum-
mary of the GO categories and create graphs for a better
visualization of the data, determining which classes of
gene products are over-represented or under-represented
on each of the three ontologies for cloned embryos com-
pared to IVF embryos. GOSlimViewer results are summa-
rized in Figures 3, 4 and 5.
Gene expression analysis by real time RT-PCR
In order to confirm the accuracy of microarray data, the
following 11 genes were selected based on their relevance
during embryonic development: DNMT3A, DNMT3B,
IGF2R, PLAC8, PGR, BIT1, HMGN3, HSPA1A, NGDN,
FBXO9, and GNAI2 (Table 5). The expression patterns of
the selected genes, obtained by Real time PCR, were con-
sistent with the results from the DNA microarray analysis
(Figure 6 and 7 ). The analysis of gene expression in the
cell lines showed that both housekeeping genes, GAPDH
and 18S ribosomal RNA, had a similar pattern of expres-
sion. The internal standard 18S ribosomal RNA values
were 1.5 times greater in all groups than those of GAPDH.
After normalization based on both housekeeping genes,
there were no differences among the groups for NFYA and
Taspase 1 genes. Both G1 and G2 cell lines had signifi-
cantly greater concentration of PALLD transcript com-
pared to G0, G4 and, and G5. For GATM, the transcript
levels of G5 were significantly lower than in all of the
other groups (Figure 8).
Data modelling
The pathways originated using Ingenuity Pathway Analy-
sis showed the most important pathways in which the dif-
ferentially expressed genes participate. The top networks
formed by the genes upregulated in IVF embryos com-
pared to both CT groups included cellular growth andPage 4 of 23
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Hierarchical clustering of microarray hybridizationsFigure 2
Hierarchical clustering of microarray hybridizations. Cluster analysis of hybridizations and genes performed using Gen-
eTraffic UNO (Iobion Informatics LLC). All donor cells were clustered in one group, while all the embryos were clustered in a 
second group. The embryos clearly separate into two groups: a group containing the IVF embryos and a group containing the 
chromatin transfer embryos.
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and organization, cellular death and response to stress
(Figure 9). On the other hand the networks obtained from
the transcripts more abundant in the cloned blastocysts
compared to IVF embryos were cellular morphology cellu-
lar development, cell signaling, and metabolism (Figure
10). Genes with a putative cumulative misregulation after
serial rounds of chromatin transfer are presented on
Tables 6 and 7.
Discussion
It has been reported that in vitro culture conditions alter
gene expression and may lead to developmental aberra-
tions in IVF derived cattle, commonly referred to as the
large offspring syndrome [38-40]. In the case of embryos
produced by SCNT, besides the alterations due to in vitro
culture conditions, gene expression defects may be caused
by improper silencing and activation of specific genes,
altered chromatin remodelling, and epigenetic alterations
[41]. But identifying key genes responsible for the general
developmental failure in cloned embryos is not an easy
task, since the alterations may be caused by a variety of
factors including donor cell type, cell cycle stage, nuclear
transfer protocol, source of the oocytes, embryo culture
system, embryo transfer procedure, recipient cows man-
agement, and operators' skills [42]. Consequently, there is
a big variety of alterations that are not always shared by all
cloned embryos. Still, the common thread uniting many
Table 1: Number of differentially expressed transcripts in pairwise comparisons between IVF embryos, CT1 embryos, CT4 embryos, 
DC1 cells, and DC4 cells (p-value < 0.01 and fold change > 2.0)
Comparison
Group 1 vs. Group 2
Differentially expressed transcripts Higher in the first group Higher in the second group
1 IVF embryos vs. CT-1 embryos 270a 123 147
2 IVF embryos vs. CT-4 embryos 411a 193 218
3 IVF embryos vs. DC-1 cells 3360c 1548 1812
4 IVF embryos vs. DC-4 cells 3428c 1593 1835
5 CT-1 embryos vs. CT-4 embryos 193a 91 101
6 CT-1 embryos vs. DC-1 cells 2459b 1238 1221
7 CT-1 embryos vs. DC-4 cells 2588b 1379 1209
8 CT-4 embryos vs. DC-1 cells 2036b 1151 885
9 CT-4 embryos vs. DC-4 cells 2276b 1287 989
10 DC-1 cells vs. DC-4 cells 83d 34 49
Different subscripts indicate statistically significant differences in the number of differentially expressed transcripts.
Table 2: Classification of differentially expressed probe sets in pairwise comparisons
Comparisons
Probe set category IVF vs. 
CT1
IVF vs. 
CT4
IVF vs. 
DC1
IVF vs. 
DC4
CT1 vs. 
CT4
CT1 vs. 
DC1
CT1 vs. 
DC4
CT4 vs. 
DC1
CT4 vs. 
DC4
DC1 vs. 
DC4
Genes 63 104 747 763 44 574 563 421 461 23
Similar to... 106 180 1564 1597 81 1071 1132 898 995 34
Hypothetical proteins 4 10 90 102 0 69 80 65 76 6
cDNA clones 0 1 24 28 0 19 16 17 16 0
Transcripts with strong 
similarity to a known 
gene
1 3 26 23 0 17 17 19 21 0
Transcripts with 
moderate similarity to a 
known gene
2 0 24 27 2 13 16 12 14 2
Transcripts with weak 
similarity to a known 
gene
1 0 13 15 1 10 17 8 10 0
Unknown transcripts 93 113 872 873 64 686 747 596 683 18
Total 270 411 3360 3428 192 2459 2588 2036 2276 83
The probe set categories correspond to NetAffx Bovine GeneChip (Nov. 2007 Annotation).Page 6 of 23
(page number not for citation purposes)
BMC Genomics 2009, 10:190 http://www.biomedcentral.com/1471-2164/10/190of the SCNT failures can be traced to epigenetic altera-
tions, specifically failures in chromatin remodelling and
DNA and histone methylation [13,43,44]. The fetal
fibroblast cells used in this study are not fully representa-
tive of adult somatic cells. However, these cells were cho-
sen because of their practicality and higher efficiency in
SCNT studies.
Microarray analysis has been used to explore the transcrip-
tome profile of cloned embryos relative to that of the
donor cells and IVF embryos as a control. However, the
appropriate microarray platform is crucial in order to
detect changes in particular genes. Smith and colleagues
reported similar transcriptome profiles for cloned blasto-
cysts and blastocysts produced by artificial insemination
[15]. However, the cDNA microarray used by Smith and
colleagues consisted of placenta and spleen cDNA librar-
ies, lacking embryonic genes, which therefore were not
analysed. The results from the present study show an
extensive reprogramming in cloned embryos by the blast-
ocyst stage. However, the data point to a group of differ-
entially expressed transcripts between IVF and cloned
blastocysts.
Serial cloning is often performed for the production of
transgenic animals. Although apparently healthy animals
can be obtained after serial cloning, the efficiency of clon-
ing decreases from generation to generation despite com-
parable blastocyst and early pregnancy rates. This increase
in pregnancy losses and perinatal deaths could be caused
by gene expression defects accumulated throughout the
serial cloning procedures, which could be detected in
blastocysts, although no phenotypic alterations are
observed at this stage. Furthermore, it has been proposed
Table 3: Top 30 upregulated genes, in IVF blastocysts compared to CT blastocysts sorted by P-value
Probe set ID Gene Title Gene ID P value Fold change IVF/CT1 Fold change IVF/CT4
Bt.28010.1.S1_at Peptidase inhibitor 3, skin-derived (SKALP) PI3 0.000000 5.58 9.12
Bt.21013.1.S1_at Polo-like kinase 3 (Drosophila) PLK3 0.000001 3.99 9.09
Bt.28223.1.S1_at 20-beta-hydroxysteroid dehydrogenase-like MGC127133 0.000009 2.13 1.71
Bt.9525.1.A1_at Zinc finger protein 183 ZNF183 0.000057 2.13 3.62
Bt.2892.1.S1_at Fatty acid binding protein 7, brain FABP7 0.00014 1.22 6.35
Bt.4430.1.S2_at ATPase, H+ transporting, lysosomal V0 
subunit a1
ATP6V0A1 0.00014 1.89 1.93
Bt.5154.1.S1_at Heat shock 70 kDa protein 1A HSPA1A 0.0002 4.14 7.17
Bt.15787.1.S1_at Bcl-2 inhibitor of transcription BIT1 0.0002 1.49 2.01
Bt.13544.2.S1_a_at Zinc finger protein 410 ZNF410 0.0003 2.01 1.90
Bt.2005.1.S1_at LSM1 homolog, U6 small nuclear RNA 
associated
LSM1 0.0003 1.86 1.57
Bt.16291.1.A1_at Testis expressed 12 TEX12 0.0004 3.40 3.64
Bt.27854.1.S1_at Nuclear factor, interleukin 3 regulated NFIL3 0.0004 1.72 3.08
Bt.13928.2.S1_a_at Sodium channel modifier 1 SCNM1 0.0004 2.02 4.05
Bt.15334.2.A1_at Signal transducer and activator of 
transcription 3
STAT3 0.0005 4.71 16.06
Bt.12506.1.S1_at Serpin peptidase inhibitor, E member 2 SERPINE2 0.0005 1.52 1.42
Bt.20204.1.S1_at Sjogren's syndrome/scleroderma autoantigen SSSCA1 0.0005 1.61 2.93
Bt.20199.1.A1_at DEAD (Asp-Glu-Ala-Asp) polypeptide 56 DDX56 0.0006 1.45 1.79
Bt.3359.1.S1_at General transcription factor IIF, polypeptide GTF2F1 0.0009 1.53 1.98
Bt.2958.1.A1_at Ubiquitin-conjugating enzyme E2A 
(RAD6 homolog)
UBE2A 0.001 2.03 3.08
Bt.3002.1.S1_at BUB3 budding uninhibited by benzimidazoles 
3
BUB3 0.001 1.27 1.62
Bt.6087.1.S1_at Transmembrane 4 superfamily member 1 TM4SF1 0.001 2.29 6.62
Bt.4737.1.S2_s_at Prion protein PRNP 0.001 2.20 2.99
Bt.1854.1.S1_at Intraflagellar transport 20 homolog 
(Chlamydomonas)
IFT20 0.001 1.65 2.30
Bt.5340.1.S1_s_at Nucleoside-diphosphate kinase NBR-A NBR-A 0.002 1.42 1.76
Bt.8.1.S1_at Keratin 10 (epidermolytic hyperkeratosis) KRT10 0.002 1.98 3.39
Bt.27095.1.S1_at Collaborates/cooperates with ARF protein CARF 0.002 1.53 2.97
Bt.5039.1.S1_at High mobility group nucleosomal binding 
domain 3
HMGN3 0.002 1.72 2.96
Bt.27874.1.S1_s_at Phosphatidylserine receptor PTDSR 0.002 2.29 2.99
Bt.4595.1.S1_at TSR2, 20S rRNA accumulation, homolog TSR2 0.002 2.08 2.59
Bt.1505.1.S1_at Sin3A-associated protein, 18 kDa SAP18 0.003 2.24 2.48
Genes were analyzed by one-way ANOVA.Page 7 of 23
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selection procedures, may induce changes in the donor
cells [36]. The present studies show that serial cloning
does not significantly affect transcriptional reprogram-
ming of cloned blastocysts. The global transcriptome pro-
file of blastocysts from four consecutive rounds of cloning
did not significantly differ from the one obtained from
blastocysts after only one round of cloning. However, for
a set of genes, misregulation was significantly greater in
the blastocysts obtained from four rounds of cloning (see
Tables 6 and 7). However the observed differences
between blastocysts from the first and fourth rounds of
cloning could be due to the fact that these are different
donor cells and not of the same clonal origin.
To our knowledge this is the first study to focus on the
influence of serial chromatin transfer on global transcrip-
tome profile of embryos and donor cells. Only a small
proportion of the data set generated by the present study
corresponded to fully annotated bovine genes (Table 2).
The rest of the probe sets were excluded from further anal-
yses due to lack of annotations. Progress in the annotation
of the bovine genome will greatly facilitate global gene
expression studies in the bovine species.
In the present study, multiple comparisons revealed five
distinctive patterns of differential gene expression among
all embryos and donor cells. The first pattern corre-
sponded to 1,183 transcripts (30.74% of the data set) that
had similar abundance in all five groups. Housekeeping
genes like GAPD and Actin showed this pattern of expres-
sion. The second pattern corresponded to genes that had
similar expression in IVF and CT embryos, but had a very
different pattern of expression in both donor cell lines.
We hypothesised that these are genes that switched from
the "donor cell gene expression mode" to the "embryo
gene expression mode". The majority of the genes in the
data set (76.49%) showed this pattern, including some
imprinted and embryonic specific genes such as the Oct-4
protein coding gene (POU5F1), which has been reported
Table 4: Top 30 genes upregulated in CT blastocysts and donor cells compared to IVF blastocysts, sorted by P-value
Probe set ID Gene Title Gene ID P value Fold change CT1/IVF Fold change CT4/IVF
Bt.8933.1.S1_at Adaptor-related protein complex 3, sigma 2 AP3S2 0.0001 1.61 2.21
Bt.27382.1.A1_s_at X-ray repair complementing defective repair in 
Chinese hamster cells 1
XRCC1 0.0001 2.60 2.54
Bt.22224.1.S1_at insulin receptor substrate 4 IRS4 0.0002 2.31 2.10
Bt.3220.1.S1_at Crystallin, lambda 1 CRYL1 0.0003 1.94 1.82
Bt.7805.2.S1_a_at Nuclear casein kinase and cyclin-dependent 
kinase substrate 1
NUCKS1 0.0003 3.14 3.47
Bt.29540.1.S1_at Arginine/serine-rich coiled-coil 1 RSRC1 0.0004 1.57 3.09
Bt.19690.1.A1_at Paraoxonase 1 PON1 0.0005 1.53 3.74
Bt.20444.1.S1_at thyroid hormone receptor associated protein 5 THRAP 0.0006 1.60 1.20
Bt.16122.1.S1_at Sorbitol dehydrogenase SORD 0.0008 2.59 3.40
Bt.5737.1.S1_at vacuolar protein sorting 26 homolog A VPS26 0.0008 2.33 3.38
Bt.4292.1.S1_at ARP3 actin-related protein 3 homolog (yeast) ACTR3 0.0008 1.69 1.69
Bt.18230.1.S1_a_at Nuclear autoantigenic sperm protein NASP 0.0011 1.95 2.75
Bt.9107.1.S1_a_at phosphatidylinositol binding clathrin assembly 
protein
PIBCAP 0.0014 1.83 2.93
Bt.663.1.S1_at Palladin, cytoskeletal associated protein PALLD 0.0019 2.88 3.08
Bt.1743.2.S1_a_at Phenylalanyl-tRNA synthetase 2, mitochondrial FARS2 0.0021 1.64 2.98
Bt.13205.1.A1_at Mitochondrial ribosomal protein S35 MRPS35 0.0023 1.44 2.29
Bt.25100.1.A1_at Cortactin CTTN 0.0026 1.26 1.58
Bt.783.1.S1_at Aldehyde oxidase 1 AOX1 0.0029 1.99 3.67
Bt.23608.1.S1_s_at Keratin 8 KRT8 0.0030 3.99 4.59
Bt.27284.1.S1_at Eukaryotic translation initiation factor 4H 
isoform 2
WBSCR1 0.0038 2.21 1.55
Bt.10898.1.S1_at Tumor differentially expressed 2-like TDE2L 0.0041 1.98 5.08
Bt.28745.1.S1_at Coagulation factor II receptor-like 1 F2RL1 0.0045 2.25 1.85
Bt.5267.1.S1_at Annexin A6 ANXA6 0.0046 1.92 3.79
Bt.355.1.S1_at Caldesmon 1 CALD1 0.0047 1.71 1.79
Bt.20084.2.S1_at Casein kinase 1, epsilon CSNK1E 0.0053 3.90 2.64
Bt.2823.3.S1_a_at Chromosome 1 open reading frame 35 C1orf35 0.0058 1.45 1.78
Bt.7671.1.S1_at Interferon induced transmembrane protein 1 IFITM1 0.0069 2.47 2.60
Bt.5319.1.S1_at Anti-oxidant protein 2 
(independent phospholipase A2)
AOP2 0.0071 2.03 3.70
Bt.23263.1.S1_s_at Heat shock 90 kDa protein 1, beta HSP90AB1 0.0072 1.30 1.90
Bt.19709.1.S1_at LAG1 homolog, ceramide synthase 2 LASS2 0.0072 1.25 1.69Page 8 of 23
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GoSlimViewer graph of Cellular Component over-represented terms in IVF and CT embryosFigure 3
GoSlimViewer graph of Cellular Component over-represented terms in IVF and CT embryos. Sub-cellular loca-
tions of gene products found at high levels in both IVF blastocysts (solid bars) and both groups of CT blastocysts (open bars). 
The proportion of genes present in the nucleus was higher in IVF embryos (31%) compared to CT embryos (5%). There were 
more membrane and intracellular genes in CT embryos compared to IVF embryos.
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GoSlimViewer graph of Biological Process over-represented terms in IVF and CT embryosFigure 4
GoSlimViewer graph of Biological Process over-represented terms in IVF and CT embryos. Biological processes 
of gene products found at high levels in both IVF blastocysts (solid bars) and CT blastocysts (open bars). No genes involved in 
development were upregulated in CT blastocysts compared to IVF blastocysts, for which 11% of the genes were involved in 
development. Conversely a greater proportion of metabolism genes were overrepresented in CT embryos compared to IVF 
embryos.
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BMC Genomics 2009, 10:190 http://www.biomedcentral.com/1471-2164/10/190as differentially expressed for cloned embryos in previous
studies [21,23]. Placenta specific 8 (PLAC8) also shows
this pattern of expression (Figure 6A). It is possible that
some genes, due to their methylation pattern in the
somatic cells or to their location in the chromosome, are
more likely to be reprogrammed by the oocyte factors.
The third pattern corresponded to genes with a similar
pattern of expression for CT embryos and donor cells, and
a very different expression pattern in IVF embryos. These
were 147 (3.81%) genes with apparently incomplete
reprogramming, probably with a somatic cell pattern of
expression. The heat shock 70 kD protein 1 (HSPA1A),
involved in cell protection from stress and apoptosis was
significantly higher in IVF embryos when compared to CT
embryos and donor cells (Figure 6B). Important embry-
onic genes showed this pattern of expression. Desmocol-
lin 3 (DSC3) a transmembrane glycoprotein, involved in
cell adhesion that belongs to the cadherin family, was
present in IVF embryos but was absent in CT embryos and
donor cells. The signal transducer and activator of tran-
scription 3 (STAT3), was significantly upregulated in IVF
embryos when compared to both groups of cloned
embryos and donor cells. A similar pattern was observed
for high mobility group nucleosomal binding domain 3
(HMGN3) a gene involved in chromatin remodelling, a
vital process during embryonic genome activation (Figure
6C). The importance of both genes during morulae and
blastocyst formation could make them good candidates in
understanding the lower developmental rates of cloned
embryos.
The fourth group of genes corresponded to only 85 probe
sets (2.21%) with a marked differential expression in all
cloned embryos compared to the one observed in both
IVF embryos and donor cells. The misregulation of these
genes could point to a compensation mechanism after
chromatin transfer. Genes with this kind of expression
pattern included prostaglandin-endoperoxide synthase
(PTGS2) and the transcription factor GATA-2. Both genes
had a greater microarray signal in all CT embryos, but low
expression in IVF and donor cells. The imprinted gene gly-
cine amidinotransferase (GATM), showed significantly
greater values in the cloned embryos compared to IVF
embryos and donor cells. Two interesting genes in this
group were DNMT3A and DNMT3B transcripts, which are
responsible for de novo methylation. Both genes were sig-
nificantly greater in CT-1 and CT-4 embryos compared to
IVF blastocysts (Figure 6D and 6E), which is consistent
with the hypermethylation often reported in cloned blas-
GoSlimViewer graph of Molecular Function over-represented terms in IVF and CT embryosFigure 5
GoSlimViewer graph of Molecular Function over-represented terms in IVF and CT embryos. Molecular functions 
of gene products found at high levels in IVF blastocysts (solid bars) and CT blastocysts (open bars). Genes with receptor func-
tion were higher in IVF blastocysts, while genes with catalytic, signal transduction and transporter functions were overrepre-
sented in CT blastocysts.
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BMC Genomics 2009, 10:190 http://www.biomedcentral.com/1471-2164/10/190tocysts. These results do not agree with previous findings,
in which DNMT3A was downregulated in NT embryos
compared to IVF embryos [21]. Zhou et al., reported sim-
ilar levels of DNMT3B for embryos produced in vivo, in
vitro, and by different nuclear transfer methods, including
chromatin transfer [9]. These contrasting results confirm
that alterations greatly vary and are not shared by all
cloned embryos. One limitation of our study is that we
have not used in vivo blastocysts which might have pro-
vided more biological means and as the physiological
standard against in vitro culture conditions.
A fifth pattern corresponded to genes that had an increas-
ing or a decreasing pattern of expression from IVF
embryos through donor cells showing an intermediate
pattern of expression in CT embryos. In total, 245 probe
sets showed this pattern of expression with 119 (3.08%)
increasing, and 126 (3.28%) decreasing from IVF through
DC. It could be assumed that these genes have been par-
tially reprogrammed, since their transcript abundance is
in between IVF and donor cells. The imprinted gene insu-
lin-like growth factor 2 receptor (IGF2R), one of the most
studied genes in the large offspring syndrome, showed
similar expression values in IVF and CT1 embryos, but sig-
nificantly higher signals in CT4 embryos, and very high
signals in both donor cells (Figure 6F). These higher
mRNA levels in the fourth generation of cloning could
indicate a cumulative misregulation of this gene. The Bcl-
2 inhibitor of transcription (BIT1) showed the greatest
values in IVF embryos, intermediate values in CT embryos
and the lowest values in donor cells (Figure 7A). The
nuclear transcription factor Y, alpha (NFYA), showed a
similar expression pattern in both IVF and CT1 embryos;
although it was significantly lower in CT4 embryos and
donor cells. Neuroguidin (NGDN), an eukaryotic transla-
tion initiation factor with important functions in embry-
onic development was another gene with a decreasing
pattern of expression (Figure 6B). Genes with and increas-
ing pattern of expression included F-box protein 9
(FBXO9), and guanine nucleotide binding protein alpha
inhibiting activity polypeptide 2 (GNAI2) represented in
Figure 6C and Figure 6D, respectively. Transcripts for the
Table 5: Primers used for Real time PCR validation
Genes Primer sequences and positions (5' - 3') Fragment size (bp) Accession Number
GAPDH_F TGCTGGTGCTGAGTATGTGGT (333–354) 295 [GenBank:XM_865742]
GAPDH_R AGTCTTCTGGGTGGCAGTGAT (627–648)
DNMT3A_F CTGGCTCTTTGAGAATGTGGTG (2372–2394) 236 [GenBank:XM_867643]
DNMT3A_R TCACTTTGCTGAACTTGGCTATT (2607–2630)
DNMT3B_F GGGAAGGAGTTTGGAATAGGAG (698–720) 417 [GenBank:NM_181813]
DNMT3B_R CTCTGGTTGCTTGTTGTTAGGTT (1114–1137)
IGF2R_F AACCAGGTGATTTAGAAAGTGCC (1939–1962) 397 [GenBank:NM_174352]
IGF2R_R CGCTTCTCGTTATTGTAGGGTG (2335–2357)
PLAC8_F TGTTTCACAGCCAGGTTACAGC (168–190) 200 [GenBank:NM_001025325]
PLAC8_R GGGTCCGATACATTGTCCTCAT (367–389)
PGR_F TAAATGACCAGCAAGCAGAAACT (562–585) 394 [GenBank:XM_613908]
PGR_R GGTAATTGTGCAGCAATAACCTC (955–978)
BIT1_F CGGAGCCAGAGGAAGAATGA (75–95) 445 [GenBank:NM_001034519.1]
BIT1_R TGCTTGTAGGCAGAAACAGCA (519–530)
HMGN3_F GTTCCAGCCCGTTGCTTTAC (22–42) 355 [GenBank:NM_001034504.1]
HMGN3_R GACCATTCATTCTCCCTCGTTAG (376–399)
HSPA1A_F CACGATGTTGATCCTGTGGG (86–106) 380 [GenBank:NM_174550.1]
HSPA1A_R CACCTTAGGCTTGTCTCCGTC (465–487)
NGDN_F GTGAGAATGACCCACTCCGTT (403–424) 397 [GenBank:NM_001046459]
NGDN_R TCCCGCTTGCTGACACTTAA (799–819)
FBXO9_F GCAGACGGCAGGAGTAGACAC (231–252) 445 [GenBank:NM_001034412.1]
FBXO9_R ACAAGTTGCATAGCCCTACGAT (675–697)
GNAI2_F TCCAGACAACTGCCAACATCA (1978–1999) 215 [GenBank:XM_589440.3]
GNAI2_R CAAACCAGGTGAACAATTCCATA (2192–2215)
PALLD_F AGGTTGACCTACGAGGAAAGGA (2071–2092) 292 [GenBank:XM_869983.2]
PALLD_R ATGTGAACGTCGCAGGCATA (2362–2382)
NFYA_F CGGGCTAAATTAGAAGCAGAAG (998–1020) 311 [GenBank: NM_001014956.1]
NFYA_R AGGGCAGAATGTGATCGTCAG (1308–1329)
GATM_F ATTGGCTGCTCAGGGAAAGT (824–844) 262 [GenBank: NM_001045878.1]
GATM_R ACATGGTCGGTCAGGGTTG (1085–1104)
TASPASE1_F CAAGACTCATATTTCCAGACTCCC (1145–1169) 264 [GenBank: NM_001034577.1]
TASPASE1-R CCAAGCACTAACTACAGCAGCAC (1408–1431)Page 11 of 23
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BMC Genomics 2009, 10:190 http://www.biomedcentral.com/1471-2164/10/190Table 6: Genes with putative cummulative downregulation in blastocysts obtained after serial rounds of chromatin tranfer
Probe Set ID Gene Title Gene Symbol IVF CT1 CT4 Fold change IVF/
CT1
Fold change IVF/
CT4
Bt.5154.1.S1_at heat shock 70 kD protein 
1
HSPA1A 16655.53 4021.00 2975.26 4.14 5.60
Bt.9759.1.S1_a_at neuroguidin, EIF4E binding 
protein
NGDN 11691.84 5346.60 3041.70 2.19 3.84
Bt.5039.1.S1_at high mobility group 
nucleosomal binding 
domain 3
HMGN3 11195.32 6522.85 4078.53 1.72 2.74
Bt.9759.2.S1_at neuroguidin, EIF4E binding 
protein
NGDN 5999.87 2431.02 1665.35 2.47 3.60
Bt.4737.1.S2_s_at prion protein PRNP 3552.73 1614.40 1425.30 2.20 2.49
Bt.1854.1.S1_at intraflagellar transport 
protein 20
IFT20 3526.47 2139.25 1380.10 1.65 2.56
Bt.27874.1.S1_s_at phosphatidylserine 
receptor
PTDSR 3476.73 1517.25 980.58 2.29 3.55
Bt.15787.1.S1_at Bcl-2 inhibitor of 
transcription
BIT1 2989.58 2007.15 1415.27 1.49 2.11
Bt.20204.1.S1_at Sjogren's syndrome/
scleroderma autoantigen 1
SSSCA1 1695.08 1056.05 579.62 1.61 2.92
Bt.4595.1.S1_at TSR2, 20S rRNA 
accumulation, homolog 
(S. cerevisiae)
TSR2 1567.39 755.35 568.11 2.08 2.76
Bt.12250.1.S1_at chromosome 14 open 
reading frame 10
C14orf10 1525.13 981.80 567.59 1.55 2.69
Bt.27095.1.S1_at collaborates/cooperates 
with ARF (alternate 
reading frame) protein
CARF 1390.25 907.40 668.85 1.53 2.08
Bt.13928.2.S1_a_at sodium channel modifier 1 SCNM1 786.05 390.50 249.35 2.01 3.15
Bt.6620.1.S1_at myosin, heavy polypeptide 
7, cardiac muscle, beta
MYH7 673.53 219.15 135.85 3.07 4.96
Bt.19972.1.S1_at proton-dependent 
gastrointestinal peptide 
transporter
PEPT1 567.85 189.46 170.27 3.00 3.34
Bt.28010.1.S1_at protease inhibitor 3, skin-
derived (SKALP)
PI3 510.98 91.50 56.05 5.58 9.12
Bt.5126.1.S1_at hypertension-related 
calcium-regulated gene
COMMD5 449.40 335.50 176.24 1.34 2.55
Bt.22523.1.S1_at dispatched homolog 1 
(Drosophila)
DISP1 402.17 174.75 155.13 2.30 2.59
Bt.5828.1.S1_at SERTA domain containing 
1
SERTAD1 357.71 287.95 157.44 1.24 2.27
Bt.333.1.S1_at transition protein 1 (during 
histone to protamine 
replacement)
TNP1 233.38 155.00 98.93 1.51 2.36
Bt.14098.1.S1_at microtubule-associated 
protein, RP/EB family, 
member 2
MAPRE2 199.89 183.45 69.82 1.09 2.86
Bt.4158.1.A1_at oviduct specific 
glycoprotein
OVGP1 196.48 168.70 78.09 1.16 2.52
Bt.22856.1.S1_at neurofilament, medium 
polypeptide
NEF3 188.69 126.35 46.89 1.49 4.02
Bt.9807.1.S1_at glycoprotein 
(transmembrane) nmb
GPNMB 154.95 52.30 24.03 2.96 6.45
Bt.23151.1.S1_at fucosyltransferase 10 
(alpha (1,3) 
fucosyltransferase)
FUT10 154.43 114.10 55.12 1.35 2.80
Bt.7239.1.S1_at solute carrier family 6 
(neurotransmitter 
transporter, dopamine), 
member 3
SLC6A3 149.32 48.30 21.24 3.09 7.03
Bt.12739.2.S1_a_at membrane-associated ring 
finger (C3HC4) 2
C3HC4 110.18 51.40 23.87 2.14 4.62
Bt.6556.1.S1_at regakine-1 protein LOC504773 89.66 25.75 39.07 3.48 2.29Page 12 of 23
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IVF embryos compared to CT embryos and donor cells
(Figure 6E). Among this group of transcripts could be
genes that are cumulatively affected be serial cloning.
Based on the difference in gene expression for RARB,
CRAB1, THBS, SERPINB5, and HLA-A, Beyhan et al. sug-
gest a possible role for the retinoic acid signalling pathway
in the failures observed in cloned bovine embryos [22].
However the bovine GeneChip does not contain a Retin-
oic Acid Receptor Beta (RARB) probe set. It only contains
a probe set that corresponds to a bovine EST with similar-
ity to the rat RARB (Bt.21044.2.A1_at). In the present
data, CRAB1 and THBS2 were slightly higher in IVF
embryos, although without statistical significance. They
also found differential gene expression among several
genes in both donor cells (CDKN1C, COPG2, DCN,
GATM, MEST, NDN, NNAT, PON3, and SGCE). In the
current study GATM was significantly downregulated in
donor cells from the fifth successive generation of chro-
matin transfer (Figure 7).
At the blastocyst stage there is an extensive reprogram-
ming of cloned embryos leading to very similar transcrip-
tomes in IVF and CT blastocysts. However, there were
around 200 differentially expressed genes in both CT
embryos compared to IVF. For some genes, the differences
were significantly greater in CT4 when compared to CT1,
suggesting a possible cumulative missregulation caused
by serial cloning. Genes involved in transcription, cellular
proliferation, embryonic development, cellular death,
and response to stress are over represented in IVF
embryos; many of these genes are present in the nucleus,
which was the cell component overrepresented in IVF
embryos. Genes involved in cell morphology, cell devel-
opment, and metabolism were over expressed in donor
cells and in cloned embryos when compared to IVF, sug-
gesting that they were not properly silenced in the donor
nucleus. The up regulation of genes involved in metabo-
lism should be further explored as it could be linked to the
large size of cloned animals.
Conclusion
As gene expression profile can only show one step in cell
phenotype and function control, namely transcriptome
regulation, proteomic analysis could complement this
study by providing a more complete picture of the regula-
tion of embryonic development. With a more complete
bovine genome annotation, more of the differentially
expressed transcripts could be analyzed further providing
more information for the currently unidentified tran-
scripts, which, in the present study represented around
18% of the dataset. Gene Ontology information for a pro-
portion of the differentially expressed genes is still incom-
plete. Thus, for some of the genes the cellular component
is known, but the biological process and/or its molecular
function is not documented. It is interesting that the
majority of genes upregulated in CT blastocysts partici-
pate in metabolism processes, while the percentage of
metabolism genes in IVF blastocyst was lower compared
to signalling pathway genes.
The present study provides a data set that could be useful
in identifying epigenetic errors in cloning and may facili-
tate our understanding of the reprogramming process in
SCCT. Future studies should involve more of the succes-
sive generations of cloned embryos and their respective
donor cells to identify cumulative misregulated genes.
Gene expression studies from fetal, newborn, and placen-
tal tissues could identify genes that are responsible for
abnormalities, abortions, stillborns and low birth rate.
Functional studies should target particular genes that play
Bt.12080.2.S1_at Bernardinelli-Seip 
congenital lipodystrophy 2
BSCL2 88.59 38.70 13.83 2.29 6.41
Bt.13036.1.S1_at progesterone receptor PGR 79.73 4.69 36.57 17.02 2.18
Bt.2157.1.S1_a_at RPGR-interacting protein 
1
RPGRIP1 77.03 58.90 6.56 1.31 11.75
Bt.28409.2.S1_at DNA replication factor CDT1 71.69 55.20 12.73 1.30 5.63
Bt.3771.1.A1_at Nucleolar protein family A, 
member 1
NOLA1 69.73 21.50 21.26 3.24 3.28
Bt.27752.1.S1_at tensin 4 TNS4 69.66 43.05 8.73 1.62 7.98
Bt.13024.2.S1_at purinergic receptor P2Y 
G-protein coupled, 2
P2RY2 67.08 46.15 22.11 1.45 3.03
Bt.28017.1.S1_at vacuolar H+-ATPase LOC407191 65.07 34.20 17.47 1.90 3.73
Bt.512.1.S1_at nucleotide 
phosphodiesterase, 3'-5'-
cyclic
PDE1A 60.70 15.59 15.85 3.89 3.83
Bt.12928.1.S1_at Interleukin 13 IL13 58.85 37.70 9.25 1.56 6.36
Bt.29129.1.S1_at anterior gradient 2 
homologue
agr2 45.07 39.00 21.29 1.16 2.12
(P < 0.01).
Table 6: Genes with putative cummulative downregulation in blastocysts obtained after serial rounds of chromatin tranfer (Continued)Page 13 of 23
(page number not for citation purposes)
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Probe Set ID Gene Title Gene Symbol IVF CT1 CT4 Fold change IVF/
CT1
Fold change IVF/
CT4
Bt.4475.1.S1_at NADH dehydrogenase 
(ubiquinone) Fe-S protein 
2, 49 kDa 
(NADH-coenzyme Q 
reductase)
NDUFS2 6724.02 13373.15 14960.42 1.99 2.22
Bt.3583.1.S1_at villin 2 VIL2 6698.24 13698.40 17209.52 2.05 2.57
Bt.663.1.S1_at palladin, cytoskeletal 
associated protein
PALLD 5038.25 14502.45 19368.34 2.88 3.84
Bt.9068.1.S1_at non-muscle myosin heavy 
chain
LOC404108 3,972.71 6,504.05 8,152.57 1.64 2.05
Bt.2841.1.S1_at tryptophanyl-tRNA 
synthetase
WARS 2,665.06 4,276.85 5,569.16 1.60 2.09
Bt.4311.1.S1_at guanidine nucleotide 
binding protein, (G 
protein), alpha inhibiting 
activity polypeptide 2
GNAI2 2,389.08 3,859.15 7,740.86 1.62 3.24
Bt.962.1.S1_at golgi autoantigen, golgin 
subfamily a, 7
GOLGA7 1,689.70 2,728.90 4,288.07 1.62 2.54
Bt.760.1.S1_at zinc finger protein 313 Znf313 1,523.55 2,140.45 3,126.63 1.40 2.05
Bt.803.1.A1_at chromatin modifying 
protein 1B
CHMP1B 1,315.99 2,093.75 3,934.13 1.59 2.99
Bt.4503.1.S1_at mitochondrial carrier 
homolog 2
Mtch2 1,279.84 3,359.75 4,555.63 2.63 3.56
Bt.23603.3.S1_at F-box protein 9 FBXO9 1,058.76 1,948.25 2,813.78 1.84 2.66
Bt.7169.1.S1_at methylmalonyl Coenzyme 
A mutase
MUT 898.23 1,622.10 1,943.02 1.81 2.16
Bt.14010.1.S1_at leukotriene B4 12-
hydroxydehydrogenase
LTB4DH 841.63 5688.55 11345.50 6.76 13.48
Bt.8933.1.S1_at adaptor-related protein 
complex 3, sigma 2 
subunit
AP3S2 667.54 1,071.50 1,425.67 1.61 2.14
Bt.12261.1.A1_at taspase 1 C20orf13 435.56 1,113.20 1,293.73 2.56 2.97
Bt.4738.1.S1_at calpastatin CAST 329.41 504.45 890.74 1.53 2.70
Bt.26764.1.A1_at Lectomedin 2 LEC2 307.46 1,085.70 1,567.79 3.53 5.10
Bt.1388.1.S1_at Abl-philin 2 isoform 2 ZDHHC16 286.19 630.40 948.26 2.20 3.31
Bt.20236.1.S1_at thrombospondin repeat 
containing 1
ADAMTSL4 211.65 322.35 522.48 1.52 2.47
Bt.5330.1.S1_at lysosomal-associated 
membrane protein 1
LAMP1 194.91 174.90 1,195.48 0.90 6.13
Bt.8870.3.S1_at CGI-119 protein CGI-119 128.16 218.35 403.76 1.70 3.15
Bt.23209.1.S1_a_at lectomedin 2 LEC2 83.06 279.90 418.46 3.37 5.04
Bt.318.1.S1_at adrenergic, beta 3, 
receptor
ADRB3 26.17 52.65 89.07 2.01 3.40
Bt.4057.1.S1_at myosin, heavy polypeptide 
10, non-muscle
MYH10 21.07 38.95 83.71 1.85 3.97
Bt.4560.1.S1_s_at trophoblast Kunitz 
domain protein 1
TKDP1 21.03 43.25 88.08 2.06 4.19
Bt.22858.1.S1_at uroplakin IIIB UPK3B 16.02 16.70 100.71 1.04 6.29
Bt.12304.1.S1_at interferon-stimulated 
protein, 15 kDa
ISG15 15.51 67.95 66.46 4.38 4.29
Bt.26830.2.S1_a_at 5,10-
methylenetetrahydrofolat
e reductase (NADPH)
MTHFR 12.02 57.85 79.11 4.81 6.58
Bt.5101.1.S1_at prion protein interacting 
protein
PRNPIP 8.97 32.00 74.73 3.57 8.33
Bt.17862.1.A1_at Guanine nucleotide 
binding protein (G 
protein), alpha stimulating 
activity polypeptide 1
GNAS1 8.03 42.00 44.87 5.23 5.59
Bt.2301.1.S1_at Zinc finger protein 325 
(gonadotropin inducible 
transcription repressor-3)
ZNF325 3.81 22.10 121.65 5.80 31.93Page 14 of 23
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development and manipulate their mRNA concentrations
in SCCT embryos, to mimic that of IVF embryos.
Methods
In vitro fertilization (IVF)
Bovine oocytes were aspirated from 2–8 mm follicles of
abattoir-obtained ovaries from Holstein cows and
matured in Tissue Culture Medium (TCM-199, Gibco/
Invitrogen, Grand Island, NY) supplemented with 0.2
mM pyruvate, 0.5 g/ml FSH (Sioux Biochemicals, Sioux
City, IA), 5 g/ml LH (Sioux Biochemicals, Sioux City,
IA), 10% FCS (Gibco/Invitrogen, Grand Island, NY), 100
U/ml penicillin and 100 g/ml streptomycin (Gibco/Inv-
itrogen, Grand Island, NY) in 5% CO2 in air at 38.5°C. For
fertilization, matured oocytes were transferred to fertiliza-
tion medium and were fertilized using thawed sperm
from a Holstein bull separated by Percoll density gradient
and further incubated for 24 hours. Presumptive zygotes
were transferred to Gardner's culture medium 1 (G1) for
3 days, followed by 3–4 days culture in Gardner's culture
medium 2 (G2). Blastocysts were evaluated and graded
according the International Embryo Transfer Society
(IETS) guidelines [45]. Grade 1 blastocysts were selected,
pooled in groups of 3 blastocysts per tube, frozen (with
addition of lyses buffer from RNeasy MicroKit (Qiagen
Valencia, CA) in liquid nitrogen and stored in -80°C until
RNA isolation.
Chromatin transfer (CT)
In vitro-matured oocytes were enucleated at 20 hpm.
Bovine fetal fibroblasts after one and four rounds of clon-
ing were trypsinized and washed in Ca/Mg Hank's Bal-
anced Salt Solution (HBSS) and permeabilized by
incubation of 50,000 – 100,000 cells in 31.25 units Strep-
tolysin O (SLO-Sigma, St. Louis, MO) in 100 l for 30
minutes in a 37°C H2O bath. Permeabilized fibroblasts
were washed, pelleted and incubated in 40 l of mitotic
extract prepared from MDBK cells containing an ATP-gen-
erating system (1 mM ATP, 10 mM creatine phosphate
and 25 g/ml creatine kinase) for 30 min at 38°C. At the
end of incubation, the reaction mix was diluted with 500
l of cell culture media (Alpha MEM with 10% FBS), pel-
leted and resuspended in TL Hepes. These cells were fused
to enucleated oocytes, activated 26 h after maturation
with 5 M calcium ionophore for 4 min followed by 10
g/ml of cycloheximide and 2.5 g/ml of cytochalasin D
for 5 h. After activation, embryos were washed, and cul-
tured in SOF medium for the first 4 days with 8 mg/ml
BSA and the last three days with 10% fetal calf serum at
38.5°C and 5% CO2 in air. Grade 1 blastocysts were
pooled (3 per tube) and frozen, with addition of lysis
buffer. Embryos were stored in -80°C until RNA isolation.
Fourth generation of SCCT embryos
For subsequent rounds of cloning, CT derived bovine
blastocysts from the first generation were transferred into
hormonally synchronized cows. At seventy-days, preg-
nancies were interrupted, and foetuses recovered. Fetal
fibroblast cultures were established and used for the next
chromatin transfer process. The same procedure was done
3 times to provide a fourth generation of clones. Grade 1
blastocysts from the fourth generation were pooled (3 per
tube) and frozen, with addition of lysis buffer. Embryos
were stored in -80°C until RNA isolation.
Establishment of fetal fibroblast cell lines
Fetal cell lines were developed according. Seventy-day old
male bovine foetuses were recovered and transported to
the laboratory in Dulbecco's PBS (DPBS) with 16 ml/ml
of antibiotic-antimycotic (Gibco, Grand Island, NY), 4
ml/ml tylosin tartrate (Sigma, St. Louis, MO), and 8 ml/
ml fungizone (Gibco). Foetuses were rinsed in DPBS, the
head and internal organs were removed, and remaining
tissues were finely chopped into pieces with a scalpel
blade. The fibroblasts were separated from the tissue
pieces using 0.08% trypsin and 0.02% EDTA in PBS
(trypsin-EDTA). The cells were seeded onto 100-mm tis-
sue culture plates (Corning, VWR, Chicago, IL) in a mini-
mal essential medium (a-MEM; Gibco) supplemented
with 10% fetal calf serum (FCS; Hyclone, Logan, UT),
0.15 g/ml glutamine (Sigma), 0.003% b-mercaptoethanol
(Gibco), and antibiotic-antimycotic (Gibco). On the
same day of cloning (day 3 of seeding), the cells were har-
vested using DPBS with trypsin-EDTA solution and were
counted. One million cells were frozen in MEM with 10%
FCS, dimethyl sulfoxide (Sigma), and lysis buffer.
Bt.17862.1.A1_at Guanine nucleotide 
binding protein (G 
protein), alpha stimulating 
activity polypeptide 1
GNAS1 8.03 42.00 44.87 5.23 5.59
Bt.12304.1.S1_at interferon-stimulated 
protein, 15 kDa
ISG15 15.51 67.95 66.46 4.38 4.29
Bt.12261.1.A1_at taspase 1 C20orf13 435.56 1113.20 1293.73 2.56 2.97
Bt.3583.1.S1_at villin 2 VIL2 6698.24 13698.40 17209.52 2.05 2.57
(P < 0.01)
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Real Time PCR gene expression analysisFigure 6
Real Time PCR gene expression analysis. Validation of gene expression patterns from the microarray analysis (black 
bars) by relative quantification through Real time PCR (open bars). A. Validation of gene expression patterns of PLAC8. B. Val-
idation of gene expression patterns of HSPA1. C. Validation of gene expression patterns of HMGN3. D. Validation of gene 
expression patterns of DNMT3a. E. Validation of gene expression patterns of DNMT3b. F. Validation of gene expression pat-
terns of IGF2R.
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Real Time PCR gene expression analysis.Figure 7
Real Time PCR gene expression analysis. Validation of gene expression patterns from the microarray analysis (black 
bars) by relative quantification through Real time PCR (open bars). A. Validation of gene expression patterns of BIT1. B. Valida-
tion of gene expression patterns of NGDN. C. Validation of gene expression patterns of FBXO9. D. Validation of gene expres-
sion patterns of GNAI2. E. Validation of gene expression patterns of PGR. Real time PCR units indicate relative expression to 
the internal standard GAPDH. Different letters on top of each bar indicate significant differences in expression (P < 0.01).
BMC Genomics 2009, 10:190 http://www.biomedcentral.com/1471-2164/10/190RNA Isolation
RNA was isolated from IVF blastocysts, SCCT blastocysts,
and donor cells using the RNeasy MicroKit (Qiagen Valen-
cia, CA) according to the manufacturer's specifications.
Briefly, embryos and cells frozen at -80°C in lysis buffer
were transferred to silica-gel membrane spin columns and
washed with RW1 wash buffer and 80% ethanol. Final
RNA elution was conducted using 14 l of RNAse free
water provided in the kit. Concentration and purity of iso-
lated RNA were determined using a NanoDrop® ND-1000
Spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE). Integrity and quality were analyzed using a Bio-
analyzer 2100 RNA 6000 Picochip kit (Agilent
Technologies, Palo Alto, CA).
Microarray
Microarray hybridizations were performed in triplicate for
each of the experimental groups using Affymetrix Bovine
DNA Chips as described by the manufacturer (Affymetrix
Santa Clara, CA). Briefly, complementary DNA (cDNA)
synthesis was performed from 10 ng total RNA using the
Two-Cycle cDNA Synthesis Kit (Affymetrix Santa Clara,
CA). The MEGAscript® T7 Kit (Ambion, Inc.) was used for
the first in vitro transcription (IVT). GeneChip IVT Labe-
ling Kit was used for the second IVT and labelling of RNA.
Complementary RNA (cRNA) was fragmented and 10 g
of fragmented cRNA were hybridized to the Genechips in
a Hybridization Oven, set to 45°C and rotations of 60
rpm for 16 hours. The chips were then washed and stained
with streptavidin/phycoerythrin (SAPE) antibody solu-
tion using an Affymetrix FS-450 fluidics station. Gene-
Chips were scanned using the Affymetrix GeneChip
scanner 3300.
Microarray data processing
Images were processed with the Affymetrix GeneChip®
Operating Software (GCOS) and expression quantified
with MAS 5.0, which also provides information on signal,
detection and calculated the detection p-value. Signal
information is a numeric value indicating transcript abun-
dance for a particular probe set. Detection information
indicates whether the transcript is detected (P, present),
undetected (A, absent), or if it is at the limit of detection
(M, marginal). Detection p-value indicates the signifi-
cance of the detection call for a probe set. Only probe sets
that were called Present in at least one of the five groups
were included in the analysis. A total of 5,599 probe sets
were excluded from the analysis as they were called Absent
in all groups. The data set for further analysis included
18,396 probe sets.
Hybridization quality check
Metrics like noise, background, Scale factor, and the ratio
of intensities of 3' probes to 5' probes for Actin and
GAPDH genes were analyzed for chip quality control.
Information about the intensities of the spiked in controls
(B. subtilis genes lys, phe, thr, and dap), which were mixed
with the total RNA at known concentrations at the begin-
Real Time PCR gene expression analysis in bovine donor cells.Figure 8
Real Time PCR gene expression analysis in bovine donor cells. Gene expression analysis of PALLD, NFYA, GATM and 
Taspase1 in donor cells lines derived from 0 rounds of cloning (DC0) first round of cloning (DC1), second round of cloning 
(DC2), fourth round of cloning (DC4), and fifth round of cloning (DC5). Units indicate relative expression to the internal 
standards GAPDH and 18S rRNA. Different letters indicate significant differences in expression between different donor cell 
lines (P < 0.01).
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Display of genes with high expression in IVF embryosFigure 9
Display of genes with high expression in IVF embryos. Data modelling of genes with high expression in IVF embryos 
compared to cloned embryos. The top networks in the pathway include cellular growth and proliferation, embryonic develop-
ment, cellular assembly and organization, cellular death and response to stress and cancer.
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Display of genes with high expression in CT embryosFigure 10
Display of genes with high expression in CT embryos. Data modelling of genes with higher expression in CT embryos 
compared to IVF embryos. The top networks in the pathway include cellular morphology, cellular development, cell signalling 
and metabolism.
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amplification and labelling process independently from
the target samples. The performance of the hybridization
control genes (E. coli genes BioB, BioC and BioD and P1
Bacteriophage cre) was also used for determining the qual-
ity of each chip.
Microarray data analysis
For data visualization, the raw GeneChip signals were
uploaded into GeneTraffic UNO (Iobion Informatics
LLC), which generated scatter plots of pairwise hybridiza-
tion comparisons and Heat maps from all hybridizations
using hierarchical clustering. Power Atlas, a web-based
resource from the University of Alabama at Birmingham,
was used to estimating the power of the hybridization
given the sample size [46]. HDBStat was used for statisti-
cal analysis[47]. Data were quantile-quantile normalized
and examined for outliers using Person's correlation.
Quality control statistics included a deleted residuals
approach [37,47,48]. False discovery rates (FDR) for the
genes were calculated using t-test [49]. Fold changes were
calculated based upon the unadjusted data means in pair-
wise comparisons. Probe sets in each pairwise comparison
with a p < 0.01, and FDR of <20%, and a Fold Change
(FC) in excess of 2.0 were considered to be significant and
examined further. For multiple comparisons, One-way
analysis of variance (ANOVA) from PROC GLM in SAS 9.1
(SAS Institute inc. Carey, NC) was performed on the com-
plete data set. The Least Significant Difference (LSD) test
was used to detect significant differences between groups.
Annotation
The probe sets corresponding to differentially expressed
genes were uploaded into the Affymetrix Netaffx Analysis
Center (Bovine GeneChip annotation from November 6
2007) to retrieve updated information regarding gene
symbol, gene title, Biological Process (BP), Molecular
function (MF), and Cellular Component (CC) [50]. To
complement the annotation from Netaffx, we used the
GOAnna tool [51] from AgBase, a Mississippi State Uni-
versity curated, web-accessible resource for functional
analysis of agricultural plant and animal gene products.
For data visualization, all the GO terms associated to each
gene were uploaded into GOSlimViewer [52] another
AgBase tool that provides a high level summary of the GO
categories found in the dataset allowing a better visualiza-
tion of the data.
Data modelling
Ingenuity Pathway Analysis 5.0 from Ingenuity Systems
was used for data modelling and the analysis of networks
related to the generated data sets. Genes upregulated in
IVF embryos compared to CT embryos and donor cells
(Figure 8) and genes downregulated in IVF embryos com-
pared to CT embryos and donor cells (Figure 9) were
uploaded in the Ingenuity Pathway Analysis 5.0. Since
Ingenuity Pathway Analysis database is based on human,
mouse, and rat genes, some of the bovine names were not
recognized by the software, mostly because of different
gene symbols. For those genes, we manually identified the
human orthologous symbol.
Real time RT-PCR gene expression analysis
DNA microarray derived gene expression results for genes
DNMT3A, DNMT3B, IGF2R, PLAC8, PGR, BIT1, HMGN3,
HSPA1A, NGDN, FBXO9, and GNAI2 were confirmed by
Real time PCR using GAPDH as the reference gene. Com-
plementary DNA was generated with the First-Strand
cDNA Synthesis system for RT-PCR using SuperScript III
Platinum® Two-Step qRT-PCR Kit (Invitrogen Life Tech-
nologies, Carlsbad, CA) according to the manufacturer's
protocol. The samples were incubated for 10 min at 25°C,
50 min at 42°C and at 85°C for 5 min. Then 2 U of E. coli
Rnase H was added to each tube and incubated at 37°C
for 20 min. The cDNA was used for quantitative real-time
PCR amplification with SYBR Green I chemistry (Roche
Applied Sciences, Indianapolis, IN). Real-time quantita-
tive PCR was performed using the LightCyclerTM instru-
ment (Roche Applied Sciences, Indianapolis, IN). The real
time PCR reactions were carried out in a total volume of
10 l according to the manufacturer's manuals for DNA
Master SYBR Green I mix (Roche Applied Sciences, IN).
The primer concentrations were adjusted to 0.5 M for
each gene. Primers were designed using Primer Premier 5
software (Premier Biosoft International, Palo Alto, CA).
Primer sequences used for real time PCR are shown in
Table 1. The cycling parameters were 30 seconds at 95°C
for denaturation, 50 cycles of 2 seconds at 95°C, 10 sec-
onds at 55°C for amplification (quantification was per-
formed at this step), and 12 seconds at 72°C for
extension. The specificity of all individual amplification
reactions was confirmed by melting curve analysis. Real-
time expression values were calculated through the rela-
tive standard curve method, using 10-fold serial dilutions
for both the target and the endogenous reference genes by
measuring the cycle number at which exponential ampli-
fication occurred in a dilution series of samples. Values
were normalized to the relative amounts of the control
mRNA, which were obtained from a similar standard
curve. In real time PCR reactions, the same initial
amounts of target molecules were used, and the Cp values
of control mRNA were constant in all samples.
Real time RT-PCR gene expression analysis from bovine 
fetal donor cells
Donor cell lines included in the study were fibroblasts
from non-cloned foetuses (DC0), and fetal fibroblasts
from first, second, fourth, and fifth rounds of cloning
(DC1, DC2, DC4, and DC5). RNA isolation from donor
cells and subsequent cDNA synthesis were performedPage 21 of 23
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mRNA abundance was determined for paladin (PALLD),
nuclear transcription factor Y alpha (NFYA), glycine amid-
inotransferase (GATM) and Taspase 1 (C20orf13). Quan-
titative assessment of RNA amplification was detected by
SYBR® GreenER™ qPCR SuperMixes for iCycler (Invitrogen
Life Technologies, Carlsbad, CA, 11761-100). Real-time
PCR reactions were performed using the iCycler iQ Real-
Time PCR instrument (BIO-RAD). The cycling parameters
were 50°C for 2 min, 95°C for 8 min 30 s for denatura-
tion, 40 cycles of 15 s at 95°C and 30 s at 60°C and 30 s
at 72°C for amplification and extension respectively. The
melting curve was performed starting at 55°C with a
0.5°C increase for 10 s in 80 cycles. Expression values
were calculated using the relative standard curve method.
Standard curves were generated using 10-fold serial dilu-
tions for both GAPDH and 18S ribosomal RNA. Standard
curves were also generated for all target genes by measur-
ing the cycle number at which exponential amplification
occurred.
Statistical analysis of Real Time PCR results
Results from different groups were analyzed by one-way
analysis of variance (ANOVA) by SAS 9.1 (SAS Institute
inc. Carey, NC). Differences at p < 0.001 were considered
significant. An additional analysis was performed using
Relative expression software tool (REST©, 384-beta ver-
sion May 2005) to compare all samples of each group. The
mathematical model used in the REST software is based
on the PCR efficiencies (E) and the crossing point devia-
tion between the samples (CP) [53-55].
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